Cargando…
Compassionate drug (mis)use during pandemics: lessons for COVID-19 from 2009
BACKGROUND: New emerging infections have no known treatment. Assessing potential drugs for safety and efficacy enables clinicians to make evidence-based treatment decisions and contributes to overall outbreak control. However, it is difficult to launch clinical trials in the unpredictable environmen...
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7441224/ https://www.ncbi.nlm.nih.gov/pubmed/32825816 http://dx.doi.org/10.1186/s12916-020-01732-5 |